Literature DB >> 11851647

Frequency of adverse drug reactions in children: a prospective study.

Annie Pierre Jonville-Béra1, Bruno Giraudeau, Pascal Blanc, Frèdèrique Beau-Salinas, Elisabeth Autret-Leca.   

Abstract

AIMS: To assess the frequency of adverse drug reactions (ADRs) in children in France.
METHODS: In a prospective study over a period of 1 week, we evaluated the incidence of ADRs (1) as a cause of admission to a regional children's hospital; (2) occurring during hospitalization in a regional children's hospital; and (3) as a cause of consultation with private paediatricians.
RESULTS: Four out of 260 children were admitted to the regional children's hospital for ADRs (1.53% [0.42, 3.89]) and six developed ADRs during hospitalization (2.64% [0.97, 5.66]), 4/428 attended the Accident and Emergency Department for ADRs (0.93% [0.25, 2.37]) and 8/1192 consulted a private paediatrician for ADRs (0.67% [0.29, 1.31]).
CONCLUSIONS: Our results are in agreement with the incidence of ADRs in children found in others countries.

Entities:  

Mesh:

Year:  2002        PMID: 11851647      PMCID: PMC1874283          DOI: 10.1046/j.0306-5251.2001.01535.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  17 in total

Review 1.  Adverse drug reactions in neonatal intensive care units.

Authors:  M Bonati; F Marchetti; M T Zullini; V Pistotti; G Tognoni
Journal:  Adverse Drug React Acute Poisoning Rev       Date:  1990

2.  Adverse drug reactions (ADRs) in hospitalized pediatric patients. A prospective study.

Authors:  G González-Martin; C M Caroca; E Paris
Journal:  Int J Clin Pharmacol Ther       Date:  1998-10       Impact factor: 1.366

3.  A prospective study of adverse drug reactions as a cause of admission to a paediatric hospital.

Authors:  I Martínez-Mir; M García-López; V Palop; J M Ferrer; L Estañ; E Rubio; F J Morales-Olivas
Journal:  Br J Clin Pharmacol       Date:  1996-09       Impact factor: 4.335

4.  Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies.

Authors:  J Lazarou; B H Pomeranz; P N Corey
Journal:  JAMA       Date:  1998-04-15       Impact factor: 56.272

5.  A prospective study of adverse drug reactions in hospitalized children.

Authors:  I Martínez-Mir; M García-López; V Palop; J M Ferrer; E Rubio; F J Morales-Olivas
Journal:  Br J Clin Pharmacol       Date:  1999-06       Impact factor: 4.335

Review 6.  Adverse reactions in children. Special considerations in prevention and management.

Authors:  P M Leary
Journal:  Drug Saf       Date:  1991 May-Jun       Impact factor: 5.606

7.  Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study.

Authors:  S Turner; A J Nunn; K Fielding; I Choonara
Journal:  Acta Paediatr       Date:  1999-09       Impact factor: 2.299

8.  Adverse drug reactions in paediatric outpatients.

Authors:  E Sanz; J Boada
Journal:  Int J Clin Pharmacol Res       Date:  1987

9.  Adverse drug reactions in pediatrics with a study of in-hospital intensive surveillance.

Authors:  V R Dharnidharka; P N Kandoth; R K Anand
Journal:  Indian Pediatr       Date:  1993-06       Impact factor: 1.411

10.  Adverse drug reactions in children leading to hospital admission.

Authors:  A A Mitchell; P G Lacouture; J E Sheehan; R E Kauffman; S Shapiro
Journal:  Pediatrics       Date:  1988-07       Impact factor: 7.124

View more
  17 in total

1.  Frequency and characteristics of hospital admissions associated with drug-related problems in paediatrics.

Authors:  Kylie L Easton; Colin B Chapman; Jo-anne E Brien
Journal:  Br J Clin Pharmacol       Date:  2004-05       Impact factor: 4.335

2.  The relationship between study characteristics and the prevalence of medication-related hospitalizations: a literature review and novel analysis.

Authors:  Anne J Leendertse; Djurre Visser; Antoine C G Egberts; Patricia M L A van den Bemt
Journal:  Drug Saf       Date:  2010-03-01       Impact factor: 5.606

3.  A prospective study on Adverse Drug Reactions of antibiotics in a tertiary care hospital.

Authors:  M Shamna; C Dilip; M Ajmal; P Linu Mohan; C Shinu; C P Jafer; Yahiya Mohammed
Journal:  Saudi Pharm J       Date:  2014-09       Impact factor: 4.330

4.  Monitoring adverse drug reactions in children using community pharmacies: a pilot study.

Authors:  Derek Stewart; Peter Helms; Dorothy McCaig; Christine Bond; James McLay
Journal:  Br J Clin Pharmacol       Date:  2005-06       Impact factor: 4.335

5.  Perceived adverse drug reactions among non-institutionalized children and adolescents in Germany.

Authors:  Hildtraud Knopf; Yong Du
Journal:  Br J Clin Pharmacol       Date:  2010-09       Impact factor: 4.335

6.  Adverse Drug Reactions in Children: Pediatric Pharmacy and Drug Safety.

Authors:  Michael Rieder
Journal:  J Pediatr Pharmacol Ther       Date:  2019 Jan-Feb

7.  Adverse drug reactions and off-label drug use in paediatric outpatients.

Authors:  Benjamin Horen; Jean-Louis Montastruc; Maryse Lapeyre-Mestre
Journal:  Br J Clin Pharmacol       Date:  2002-12       Impact factor: 4.335

8.  A pilot study to evaluate a community pharmacy-based monitoring system to identify adverse drug reactions associated with paediatric medicines use.

Authors:  Mansour Tobaiqy; Derek Stewart; Peter J Helms; Christine Bond; Amanda Jane Lee; Nick Bateman; Dorothy McCaig; James McLay
Journal:  Eur J Clin Pharmacol       Date:  2010-03-02       Impact factor: 2.953

9.  Prevalence of adverse drug reactions in the primary care setting: A systematic review and meta-analysis.

Authors:  Widya N Insani; Cate Whittlesea; Hassan Alwafi; Kenneth K C Man; Sarah Chapman; Li Wei
Journal:  PLoS One       Date:  2021-05-26       Impact factor: 3.240

10.  Adverse drug reactions causing admission to a paediatric hospital.

Authors:  Ruairi M Gallagher; Jennifer R Mason; Kim A Bird; Jamie J Kirkham; Matthew Peak; Paula R Williamson; Anthony J Nunn; Mark A Turner; Munir Pirmohamed; Rosalind L Smyth
Journal:  PLoS One       Date:  2012-12-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.